Skip to main content
RDY
NYSE Life Sciences

FDA Approves First Generic Rival to Gilead's Yeztugo

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$14.376
Mkt Cap
$11.802B
52W Low
$11.36
52W High
$15.67
52W Position info
27% above low
Off High info
8.3% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

RDY sits 27% above its 52-week low of $11.36.

Summary

Dr. Reddy's won FDA approval for the first generic version of Gilead's Yeztugo, a direct competitive threat to a Gilead product. For Dr. Reddy's, this is a fresh US launch opportunity in a market where North America generics revenue just dropped 29% year over year in Q2 FY2026, so a first-to-file style generic adds a needed growth lever. The approval also lands against a rough regulatory stretch: four Form 483s across its Bachupally, Mexico, FTO-11 and FTO-9 sites since mid-August, which keeps manufacturing compliance risk in view. Gilead faces the more consequential side of this — a generic entrant erodes Yeztugo's pricing and exclusivity economics. Watch Dr. Reddy's launch timing and any Gilead response on pricing or litigation.

At the time of this announcement, RDY was trading at $14.38 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.8B. The 52-week trading range was $11.36 to $15.67. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

RDY - Latest Insights

RDY
Nov 05, 2026, 6:06 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $14.75
Real-time Price: $14.90 info
Change: +$0.150 (+1%) info
Market Cap: $12.369B info
RDY
Nov 02, 2026, 12:25 PM EST
Filing Type: 144
Importance Score:
7
Price at Filing: $14.10
Real-time Price: $14.90 info
Change: +$0.805 (+6%) info
Market Cap: $12.369B info
RDY
Oct 23, 2026, 12:22 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $13.22
Real-time Price: $14.90 info
Change: +$1.69 (+13%) info
Market Cap: $12.369B info
RDY
Oct 14, 2026, 12:43 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $12.82
Real-time Price: $14.90 info
Change: +$2.09 (+16%) info
Market Cap: $12.369B info
RDY
Oct 08, 2026, 9:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $12.27
Real-time Price: $14.90 info
Change: +$2.63 (+21%) info
Market Cap: $12.369B info